Data Presented at American Society of Hematology From Ibrutinib Phase 1b/2 …

Published December 10, 2012

Data Presented at American Society of Hematology from Ibrutinib Phase 1b/2 …

Filed under: drug abuse treatment outcome study

In a study of 116 patients, the overall response rate (ORR) was 68 percent in elderly treatment-naive (TN) patients with an estimated 96 percent progression-free survival (PFS) rate at 26 months. … Patients with HR disease were previously treated and …
Read more on Sacramento Bee

An AIDS-Free Generation

Filed under: drug abuse treatment outcome study

One of the goals set forth in the National HIV/AIDS Strategy is increasing access to care and improving health outcomes for all Americans living with HIV, and in unveiling the President's Emergency Plan for AIDS Relief (PEPFAR) Blueprint this week …
Read more on AIDS.gov blog (blog)

Important Catalysts For 3 Biotech Companies

Filed under: drug abuse treatment outcome study

The study, comparing patients treated with Zohydro ER versus placebo, met the primary endpoint of efficacy, demonstrating that Zohydro ER resulted in significantly improved chronic pain relief (p=0.008). The drug is being developed in collaboration …
Read more on Seeking Alpha